Back to 
Renaissance Technologies LLC
Renaissance Technologies LLC
MCRB
Showing 0 of 17 quarters
Position history for Renaissance Technologies LLC's holdings in Seres Therapeutics, Inc.
No. Renaissance Technologies exited its MCRB (Seres Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 817,000 shares worth $1.1M. Renaissance Technologies already held MCRB in its Q3 2019 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.